Briggs Morrison is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 34,836 shares of SNDX, which is worth approximately $444,855. The most recent transaction as insider was on Feb 07, 2024, when has been sold 17,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.8K
0% 3M change
95.31% 12M change
Total Value Held $444,855

Briggs Morrison Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
BUY
Grant, award, or other acquisition
-
17,000 Added 32.8%
34,836 Common Stock
Aug 09 2023
SELL
Open market or private sale
$965,660 $18.27 p/Share
52,855 Reduced 74.77%
17,836 Common Stock
Aug 09 2023
BUY
Exercise of conversion of derivative security
$463,538 $8.77 p/Share
52,855 Added 42.78%
70,691 Common Stock
Jul 10 2023
SELL
Open market or private sale
$1,078,242 $20.4 p/Share
52,855 Reduced 74.77%
17,836 Common Stock
Jul 10 2023
BUY
Exercise of conversion of derivative security
$463,538 $8.77 p/Share
52,855 Added 42.78%
70,691 Common Stock
Jun 09 2023
SELL
Open market or private sale
$1,119,468 $21.18 p/Share
52,855 Reduced 74.77%
17,836 Common Stock
Jun 09 2023
BUY
Exercise of conversion of derivative security
$400,640 $7.58 p/Share
52,855 Added 42.78%
70,691 Common Stock
May 09 2023
SELL
Open market or private sale
$1,131,625 $21.41 p/Share
52,855 Reduced 74.77%
17,836 Common Stock
May 09 2023
BUY
Exercise of conversion of derivative security
$337,214 $6.38 p/Share
52,855 Added 42.78%
70,691 Common Stock
Apr 10 2023
SELL
Open market or private sale
$1,032,258 $19.53 p/Share
52,855 Reduced 74.77%
17,836 Common Stock
Apr 10 2023
BUY
Exercise of conversion of derivative security
$337,214 $6.38 p/Share
52,855 Added 42.78%
70,691 Common Stock
Mar 13 2023
SELL
Open market or private sale
$1,190,800 $22.53 p/Share
52,854 Reduced 74.77%
17,836 Common Stock
Mar 13 2023
BUY
Exercise of conversion of derivative security
$337,208 $6.38 p/Share
52,854 Added 42.78%
70,690 Common Stock
Feb 06 2023
SELL
Open market or private sale
$1,418,072 $26.83 p/Share
52,854 Reduced 74.77%
17,836 Common Stock
Feb 06 2023
BUY
Exercise of conversion of derivative security
$337,208 $6.38 p/Share
52,854 Added 42.78%
70,690 Common Stock
Sep 20 2022
SELL
Open market or private sale
$1,386,839 $23.25 p/Share
59,649 Reduced 76.98%
17,836 Common Stock
Sep 20 2022
BUY
Exercise of conversion of derivative security
$650,174 $10.9 p/Share
59,649 Added 43.5%
77,485 Common Stock
Sep 19 2022
SELL
Open market or private sale
$2,633,227 $23.03 p/Share
114,339 Reduced 86.51%
17,836 Common Stock
Sep 19 2022
BUY
Exercise of conversion of derivative security
$1,246,295 $10.9 p/Share
114,339 Added 46.38%
132,175 Common Stock
Sep 16 2022
SELL
Open market or private sale
$2,902,500 $23.22 p/Share
125,000 Reduced 87.51%
17,836 Common Stock
Sep 16 2022
BUY
Exercise of conversion of derivative security
$1,131,250 $9.05 p/Share
125,000 Added 63.82%
70,870 Common Stock
Sep 15 2022
SELL
Open market or private sale
$1,615,955 $24.2 p/Share
66,775 Reduced 78.92%
17,836 Common Stock
Sep 15 2022
BUY
Exercise of conversion of derivative security
$480,780 $7.2 p/Share
66,775 Added 44.11%
84,611 Common Stock
Sep 14 2022
SELL
Open market or private sale
$2,085,951 $23.8 p/Share
87,645 Reduced 83.09%
17,836 Common Stock
Sep 14 2022
BUY
Exercise of conversion of derivative security
$631,044 $7.2 p/Share
87,645 Added 45.38%
105,481 Common Stock

Also insider at

CDAK
Codiak BioSciences, Inc. Healthcare
HOWL
Werewolf Therapeutics, Inc. Healthcare
RPTX
Repare Therapeutics Inc. Healthcare
ARVN
ARVINAS, INC. Healthcare
SESN
Sesen Bio, Inc. Healthcare
BM

Briggs Morrison

Waltham, MA

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Track Activities on SNDX